EFF demands Motsoaledi resignation over R15.5 billion ARV tender scandal - IOL
The EFF is calling on Health Minister Aaron Motsoaledi's resignation after an ARVs multibillion tender irregularities.
The Economic Freedom Fighters (EFF) is demanding the resignation of Health Minister Dr Aaron Motsoaledi with immediate effect after the Pretoria High Court found irregularities in the R15.5 billion national antiretroviral tender.
This follows a judgment on October 20 by Acting Judge Graham Girdwood in a case brought by Cipla Medpro Manufacturing, one of South Africa’s oldest local ARV producers, which found the awards for Item 13 and Item 23, the R12.6bn portion covering one-month and three-month packs of dolutegravir, lamivudine and tenofovir (TLD), South Africa’s first-line HIV treatment, were unlawful, unconstitutional and must be redone within 120 days.
1. Expired factory licence: Innovata Pharmaceuticals and Viatris Healthcare used an Isando manufacturing site licence that had expired before tender closure. “A licence that has expired is not, and was not on bid closure date, a valid licence,” Girdwood ruled. Both are disqualified from reconsideration.
2. Linked bidders and possible collusion: Barrs Pharmaceuticals and Innovata, both subsidiaries of Avacare Health Group, now in business rescue submitted prices differing by only R1 for one product. Court ordered investigation into whether they prepared bids independently and ordered HDI points stripped for failing to prove ownership.
3. Wrongful local preference: Court found serious irregularities in allocating local manufacturing and HDI points.
Motsoaledi and his then then Director General were ordered to pay Cipla’s costs. Current suppliers will keep delivering for 90 days after new awards to avoid shortages.
“Instead of giving satisfactory answers, the minister sought to distance himself from procurement, saying he does not involve himself in tenders and relied on officials,” the EFF said.
The Portfolio Committee’s own statement on February 19 echoed those concerns.
EFF now wants SIU investigation, all officials involved suspended, and the tender restarted.
Cipla, which received only three minor awards worth between R214 million to R215 million despite capacity to supply over half the national demand for TLD, said it went to court to protect local manufacturing integrity.
In its founding papers, Cipla argued Item 13 and 23 are the same medicine in different packs and should not have been split to exclude capable local producers. The court agreed.
Cipla statement post-judgment said it approached the court not for commercial gain, but to ensure that South Africa’s largest ARV tender rewards proven, licensed local capacity and complies with the Constitution.
"The court has vindicated our long track record at our Durban facility” Cipla said.
Hetero Drugs, which also challenged but wanted its own exclusion reviewed, had its application dismissed.
The Department of Health welcomed the judgment and assured patients of uninterrupted supply.
“The department reassures patients that there will be no disruption in the supply of crucial antiretroviral drugs.” It said clinics and hospitals will continue dispensing as current suppliers remain contracted during the 120-day reallocation period.
Department spokesperson Foster Mohale said the are happy with the court’s clarity.
"We will comply with the order to reconsider within 120 days, and we are implementing internal controls to address licensing verification and HDI documentation issues raised.”
Asked if the Motsoaledi would resign, Mohale said calling for the minister's resignation was "just a political statement, not the position of parliament". He said MPs make similar statements all the time.


